Bangalore, Oct 22, 2009: NOTOX, a global CRO, has entered into a collaboration with Semler Research Center (SRC) in India. Together, SRC and NOTOX shall integrate their service offerings by sharing their best practices and marketing to provide a seamless bridge between these two highly regarded scientific organizations. SRC has significant expertise in a diverse range of techniques and assays supporting clinical toxicological, pharmacological, and pharmacokinetic and bioequivalence studies (phase I unit). SRC complements NOTOX’s contract research service offerings that include expertise in preclinical contract research and expert consultancy for the development of pharmaceutical products worldwide.
“This collaboration will effectively and successfully offer full-fledged preclinical services to the Indian Pharma Industry and further strengthens the service portfolio of SRC,” said Mr Ravi Achar, CFO and Managing Director of Semler Research Center.
© BioSpectrum Bureau
“This collaboration will effectively and successfully offer full-fledged preclinical services to the Indian Pharma Industry and further strengthens the service portfolio of SRC,” said Mr Ravi Achar, CFO and Managing Director of Semler Research Center.
© BioSpectrum Bureau
No comments:
Post a Comment